We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0ABR market cap is 0. The company's latest EPS is DKK 3.1564 and P/E is 1.77.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 17.67B | 16.3B | 18.25B | 19.91B | 22B |
| Operating Income | 1.99B | 2.01B | 2.85B | 3.2B | 3.27B |
| Net Income | 1.58B | 1.32B | 1.92B | 2.29B | 3.14B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 36.03B | 34.65B | 37.45B | 37.41B | 56.98B |
| Total Liabilities | 19.06B | 16.37B | 16.67B | 15.36B | 31.97B |
| Total Equity | 16.97B | 18.28B | 20.78B | 22.05B | 25.01B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 3.84B | 2.27B | 3.52B | 4.08B | 3.33B |
| Investing | -467M | -610M | -1.89B | -498M | -15.29B |
| Financing | -2.39B | -3.34B | -387M | -2.09B | 11.63B |
| Market Cap | 0 |
| Price to Earnings Ratio | 1.77 |
| Price to Sales Ratio | 0.25 |
| Price to Cash Ratio | 1.2 |
| Price to Book Ratio | 0.22 |
| Dividend Yield | - |
| Shares Outstanding | 995.74M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | H Lundbeck A/s |
| Address |
ottiliavej 9 valby DK-2500 |
| Website | https://www.lundbeck.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
